Hims & Hers Health, INC Form 4 insider transactions

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on October 2, 2024, according to a Form 4 filing with the SEC.

Hims & Hers Health's CFO, Oluyemi Okupe, sold 12,651 shares of Class A Common Stock on September 20, 2024, at an average price of $16.7857 per share.

Hims & Hers Health CEO Andrew Dudum sold shares of Class A Common Stock on September 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the vesting and disposal of restricted stock units to cover tax obligations.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Andrew Dudum, CEO of Hims & Hers Health, reports the vesting and tax withholding of restricted stock units, resulting in changes to his beneficial ownership.

Irene Becklund, PAO of Hims & Hers Health, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units, including transactions to cover tax obligations and sales under a 10b5-1 trading plan.

Director David B. Wells reports the vesting and conversion of Restricted Stock Units (RSUs) into Class A Common Stock.

Chief Medical Officer of Hims & Hers Health, Patrick Harrison Carroll, reports the vesting and sale of restricted stock units to cover tax obligations.

Chief Commercial Officer Michael Chi reports acquisition and disposal of Hims & Hers Health, Inc. Class A Common Stock and Restricted Stock Units.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports the vesting and subsequent sale of Class A Common Stock to cover tax obligations.

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on September 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,345 shares of Class A Common Stock at $14.65 per share under a pre-arranged 10b5-1 trading plan.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, executed stock option exercises and sales of Class A Common Stock between September 3rd and September 5th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

CEO Andrew Dudum exercised stock options and sold shares of Hims & Hers Health, Inc. on September 3, 2024, according to a Form 4 filing with the SEC.

Director Christiane Pendarvis of Hims & Hers Health, Inc. sold 7,000 shares of Class A Common Stock on August 27, 2024, at a price of $15.152 per share.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,334 shares of Class A Common Stock on August 20, 2024, at a price of $16.71 per share.

Irene Becklund, PAO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on August 16, 2024, under a pre-arranged 10b5-1 trading plan.

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options to acquire 6,430 shares of Class A Common Stock at $5.01 per share on August 13, 2024.

Director Kare Schultz acquired restricted stock units (RSUs) in Hims & Hers Health, Inc. on August 7, 2024, according to a Form 4 filing.

Director David B. Wells reports acquisition of 9,935 Restricted Stock Units (RSUs) in Hims & Hers Health, Inc.

Director Anja Manuel reports acquisition of 9,935 Restricted Stock Units (RSUs) convertible to Class A Common Stock of Hims & Hers Health, Inc.

Andrea Perez Garcia, a director of Hims & Hers Health, Inc., reported the acquisition of 9,935 Restricted Stock Units (RSUs) on August 7, 2024, convertible to Class A Common Stock.

Christopher D. Payne, a director of Hims & Hers Health, Inc., reported the acquisition of 9,935 Restricted Stock Units (RSUs) on August 7, 2024, convertible to Class A Common Stock.

Chief Medical Officer Patrick Harrison Carroll received 9,935 Restricted Stock Units (RSUs) convertible to Class A Common Stock, vesting by June 15, 2025, or the 2025 annual meeting, as per a recent SEC Form 4 filing.

Director Delos M. Cosgrove reports acquisition of 9,935 Restricted Stock Units (RSUs) in Hims & Hers Health, Inc.

Director Christiane Pendarvis reports acquisition of 9,935 Restricted Stock Units (RSUs) convertible to Class A Common Stock in a recent SEC filing.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,334 shares of Class A Common Stock at a price of $17.3 per share on August 6, 2024.

CEO Andrew Dudum exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, COO of Hims & Hers Health, executed stock option exercises and sales of Class A Common Stock between August 5th and August 7th, 2024, according to a pre-arranged Rule 10b5-1 trading plan.